Hughes, J.B.; Rødland, M.S.; Hasmann, M.; Madshus, I.H.; Stang, E.
Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab. Pharmaceuticals 2012, 5, 674-689.
https://doi.org/10.3390/ph5070674
AMA Style
Hughes JB, Rødland MS, Hasmann M, Madshus IH, Stang E.
Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab. Pharmaceuticals. 2012; 5(7):674-689.
https://doi.org/10.3390/ph5070674
Chicago/Turabian Style
Hughes, Juliana Bentes, Marianne Skeie Rødland, Max Hasmann, Inger Helene Madshus, and Espen Stang.
2012. "Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab" Pharmaceuticals 5, no. 7: 674-689.
https://doi.org/10.3390/ph5070674
APA Style
Hughes, J. B., Rødland, M. S., Hasmann, M., Madshus, I. H., & Stang, E.
(2012). Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab. Pharmaceuticals, 5(7), 674-689.
https://doi.org/10.3390/ph5070674